Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  4. DEFA14A Proxy Proxy Materials
  5. DEFA14A Proxy Proxy Materials
  6. DEFR14A Other DEFR14A
  7. DEFA14A Proxy Proxy Materials
  8. PRER14A Other PRER14A
  9. DEFA14A Proxy Proxy Materials
  10. DEFA14A Proxy Proxy Materials
  11. PRER14A Other PRER14A
  12. DEFA14A Proxy Proxy Materials
  13. DEFA14A Proxy Proxy Materials
  14. DEFA14A Proxy Proxy Materials
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. EFFECT Other Notice of Effectiveness
  18. CERT Other Certification
  19. 8-A12B Other Registration of Securities
  20. DRS/A Other Draft Registration Statement

Page 4 of 5 · 82 filings